PAR General discussion, page-149

whatsyourname, I agree with your est. of $1.60 - $2.20 SP range quite possibly until mid 2024 because the Instos and pro's just aren't going to get excited until P3 Zilosul results come in. Even the 008 disease modification trial hasn't fired them up, and something seems to have gone amiss with 008 anyway. As other posters have said, the main P3 OA trial can't begin until the dosing trial FDA now requires is done to determine the optimum dose. Realistically, that probably won't get done before the end of '22 or more likely mid '23. Shorters and algos will continue to play for the next 18 months minimum so patience is the only way to get our multi-bagger. My view, but it seems like quite a few Paradigmers agree. Boring news for the next 24 months is ok with me, just no bad news.